Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 May;95(5):911-918.
doi: 10.1111/ans.19369. Epub 2025 Jan 19.

Long-term effect of Roux-en-Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial

Young Min Lee  1 , Ahmed Barazanchi  1 , Jason Robertson  1 , Rinki Murphy  2 , Michael W C Booth  1
Affiliations
Randomized Controlled Trial

Long-term effect of Roux-en-Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial

Young Min Lee et al. ANZ J Surg. 2025 May.

Abstract

Background: Laparoscopic sleeve gastrectomy (LSG) is a potentially refluxogenic operation while Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) is regarded as an anti-reflux procedure. The aim of this study is to compare long-term incidence of Barrett's Oesophagus (BO) and gastroesophageal reflux disease (GORD) following LSG and LRYGB.

Methods: Participants of a double-blinded randomized controlled trial comparing banded LRYGB and LSG for remission of type 2 diabetes were contacted to take part. A gastroscopy was performed. Primary outcome was endoscopic and histologic evidence of BO. Secondary outcomes included reflux and regurgitation scores, presence of oesophagitis, proton-pump inhibitor (PPI) usage, Body Mass Index (BMI), and percentage excess weight loss (%EWL).

Results: Forty-eight of 109 patients were enrolled into the study (LSG 26 vs. LRYGB 22). Mean follow-up was 7.5 years for the LSG group, and 7.4 years for the RYGB group (P = 0.22). 8 LSG patients had BO while 3 LRYGB patients had BO (30.8%vs13.6%, P = 0.19). There was no significant difference in the mean reflux (8.1 ± 9.4(0-36) vs. 9.3 ± 8.8(0-34), P = 0.47) and regurgitation scores (7.7 ± 6.9(0-22) vs. 11.5 ± 10.5(0-44), P = 0.23) for LSG versus LRYGB patients or between those with and without BO. PPI usage before and after surgery was 6/26 (23.1%) versus 13/26 (50.0%) and 8/22 (36.4%) versus 12/22 (54.5%) for LSG and LRYGB patients respectively. PPI usage in patients with and without BO was 7/11 versus 18/37. EWL was significantly greater (P = 0.0013) in the LRYGB group (74.8 ± 28.1%) compared to LSG group (49.7 ± 18.7%).

Conclusions: Long-term incidence of BO trended towards but was not significantly higher for LSG compared to LRYGB group. We support routine endoscopic surveillance for bariatric patients.

Keywords: Barrett's oesophagus; gastric bypass; metabolic and bariatric surgery; obesity; sleeve gastrectomy.

PubMed Disclaimer

References

    1. Özsoy Z, Demir E. Which bariatric procedure is the most popular in the world? A bibliometric comparison. Obes. Surg. 2018; 28: 2339–2352.
    1. Murphy R, Evennett N, Clarke M et al. Sleeve gastrectomy versus Roux‐en‐Y gastric bypass for type 2 diabetes and morbid obesity: double‐blind randomised clinical trial protocol. BMJ Open 2016; 6: e011416.
    1. Murphy R, Clarke M, Evennett N et al. Laparoscopic sleeve gastrectomy versus banded roux‐en‐Y gastric bypass for diabetes and obesity: a prospective randomised double‐blind trial. Obes. Surg. 2017; 28: 293–302.
    1. Khezerloo JK, Nikroo ND, Jaafarinejad H et al. The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. Heliyon 2020; 6: e03496.
    1. Velanovich V. Comparison of generic (SF‐36) vs. disease‐specific (GORD‐HRQL) quality‐of‐life scales for gastroesophageal reflux disease. J. Gastrointest. Surg. 1998; 2: 141–145.

Publication types

MeSH terms